Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...
Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...
The rollout marks a major step in reducing childhood deaths from sickle cell disease through early screening and advanced ...
LONDON--(BUSINESS WIRE)--The apheresis devices market is expected to grow by USD 812.44 million during 2020-2024, according to the latest market research report by Technavio, progressing at a CAGR of ...
ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives ...
Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases. Increasing Demand for Source Plasma From Biopharmaceutical Companies. Rising Demand for Blood Components and ...
Apheresis for Leukemia and Pediatric Patients. Emerging Economies With Increasing Investments From Government Bodies and Leading Players. This study involved the extensive use of both primary and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results